Page 697 - ACCCN's Critical Care Nursing
P. 697

Research vignette, Continued
            Critique                                          Performance  Category  (CPC).  This  scale  rates  patients  from  1
            The  use  of  therapeutic  hypothermia  as  a  modality  to  improve   (normal) through to 5 (certified brain-dead) and has been used as
                                                                                                        159
            mortality and morbidity in out of hospital cardiac arrest has been   a comparable outcome measure in similar recent studies.  This
                                            147
            well  recognised  in  the  literature  since  2002.  The  International   study noted that 31 percent of participants had a CPC score of 1
            Liaison Committee on Resuscitation (ILCOR) published an advisory   or  2.  While  the  Australian  experience  has  not  been  discussed,
            statement  in 2003  recommending  the  implementation  of  thera-  generalisation  to  the  Australian  context  should  be  made  with
            peutic hypothermia.  The American Heart Association (AHA) and   caution.
                          148
            the  European  Resuscitation  Council  (ERC)  also  published  thera-  Whilst  the  researchers  claim  that  their  modality  of  therapeutic
            peutic  hypothermia  guidelines  following  the  ILCOR  2005  con-  hypothermia  is  rapid,  safe  and  low  cost,  they  highlight  that  the
                                                 149
            sensus on science and treatment recommendations,  and these   major barrier inhibiting the uptake of this treatment is technical
                                         150
            were  updated  and  republished  in  2010.   However,  as  pointed   difficulties. The researchers attribute these difficulties to the cost
            out in this paper, the uptake of therapeutic hypothermia across   of  commercial  equipment  required  to  rapidly  and  effectively
            the world has been slow and reasons for this have included the   implement therapeutic hypothermia. This cost is underexplored in
            cost of equipment used for cooling. 151-156  When referring to these   this study; it is eluded that all devices are expensive and therefore
            statements  of  utilisation,  the  reader  should  be  aware  that  the   unattainable  by  many  hospitals. The  researchers  then  state  that
            Australian experience has not been discussed and therefore gen-  their method is labour -intensive, however the cost comparison of
            eralisation  of  the  Australian  context  cannot  be  made.  Further,   the labour as opposed to use of the various devices is not explored.
            as  the  authors  note,  the  use  of  a  single  study  site  limits  the   The insertion and confirmation of nasograstric tube (NGT) occurred
            generalisability  of  the  findings.
                                                              by auscultation and aspiration of gastric fluid. Evidence cautions
            The ILCOR statement on therapeutic hypothermia states that intra-  against  the  use  of  litmus  paper,  auscultation  and  bubbling  to
            venous  ice  cold  fluids  (30 mL/kg)  can  safely  initiate  therapeutic   confirm NGT placement, with pH testing and X-ray confirmation
                                                                     161
            hypothermia and the use of ice packs and/or cooling blankets and   preferred.  Thus, the reader should be aware that the use of ice-
                                       150
            pads can maintain temperature control.  In this study, therapeutic   water gastric lavage is not supported by ILCOR and that there are
            hypothermia was initiated at 40 mL/kg; the authors do not state   inherent  risks  of  NGT  misplacement.  Replication  of  the  study
            why they used a higher fluid volume than recommended by ILCOR.   without the ice-water gastric lavage cooling technique will likely
            Similarly, the use of ice-water gastric lavage in the study has not   be beneficial.
            been  recommended  by  ILCOR.  Other  reported  methods  of  non-  The benefits of initiating mild therapeutic hypothermia following
            invasive cooling not recommended by ILCOR, but evident in the   an  OHCA  or  IHCA  are  well  documented  in  the  literature.  The
            literature,  includes  the  trans-nasal  insertion  of  an  evaporative   authors rightly note that transferring this evidence into practice
            coolant into the nasopharynx. 157-159
                                                              has  not  been  seen  and  cite  the  ease  of  cooling  processes  as
            Various methods have been documented for recording and moni-  its  potential  barrier.  In  the  study,  the  researchers  report  a  redu-
            toring  the  core  temperature,  including  involving  the  bladder,   ction in the ROSC to initiation of hypothermia time (257 to 132
                                            160
            rectum,  pulmonary  artery  and  oesophagus.   While  pulmonary   minutes)  with  targeted  education,  raising  clinical  awareness
            artery  catheters  are  considered  to  be ‘gold  standard’,  the  use  of   through  lectures  and  wide  distribution  of  cooling  protocols.
            minimally-invasive monitoring such as oesophageal temperature   Other  studies  have  also  found  an  increase  in  the  therapeutic
            monitoring is considered to be optimal.  Temperature monitor-  hypothermia  following  the  implementation  of  a  standardised
                                         159
            ing using the bladder and the rectum should be interim measures   protocol. 162,163
            only as there is typically is a ‘temperature lag time’ behind the core
            temperature. In addition, variability of measurements occurs with   The mix of patients in this study also needs consideration. Defini-
            the flow of urine presence and faeces around the catheter. Con-  tive data on benefit has been primarily based on out-of-hospital
            sistent  with  ILCOR  recommendations,  re-warming  commenced   cardiac  arrest  (OHCA)  with  ILCOR  only  highlighting  two  studies
                                                                                                           150
            after 24 hours, however the authors state that the recommended   that included both OHCA and in-hospital cardiac arrests (IHCA).
            rate is no more than 0.5 °C/h. ILCOR makes no mention of the rate   The  researchers  in  this  study  had  predominately  IHCA  patients
            of rewarming and the researchers reference this rate to Scandina-  (n  =  40)  whereas  OHCA  patients  were  of  lower  numbers  (n  =
            vian  Clinical  Practice.   The  researchers  in  the  study  achieved  a   25). This  study  is  important  as  it  adds  weight  to  the  supportive
                           44
            re-warming rate of 0.18 °C/h.                     evidence  for  therapeutic  hypothermia  for  all  patients  suffering
                                                              cardiac arrest who remain comatose post return of spontaneous
            Cognitive  preservation  was  measured  as  an  outcome  measure     circulation. Interestingly the IHCA group had better neurological
            in  the  current  study  using  the  Glasgow-Pittsburg  Cerebral   outcomes  overall  when  compared  with  the  OHCA  group.



            Learning activities

            All learning activities relate to the case study.  4.  Discuss  the  pathophysiology  of  PEA  in  relation  to  the  case
            1.  Discuss the management of this patient in relation to the ALS   study.
               flowchart.                                     5.  Outline the role of therapeutic hypothermia in post arrest care.
            2.  Discuss the ethical issues of consent and limitations of treat-  6.  Outline the postresuscitation management that is related to
               ment as related to the case study.                this case study.
            3.  Identify potential causes of PEA.
   692   693   694   695   696   697   698   699   700   701   702